Teva Pharmaceutical Industries Reports Strong Q3 Revenue Growth
Nov 6, 2024
Pharmaceuticals Equities
Alembic Pharma Secures US FDA Approval for Alcaftadine Ophthalmic Solution
Oct 4, 2024
Sanofi's Dupixent Emerges as First Biologic Treatment for COPD in China, Pioneering a New Era in Respiratory Medicine
Sep 28, 2024
Dupixent® (dupilumab) Becomes China's First Biologic for COPD through Regeneron Pharmaceuticals
Sep 28, 2024
argenx Reports Breakthrough Data from ADHERE Study in CIDP Published in The Lancet Neurology
Sep 20, 2024
Ventyx Biosciences Begins Phase 2a Trial for Parkinson's Treatment VTX3232
Sep 7, 2024
Dr. Reddy's Labs Andhra Pradesh Facility Receives EIR from USFDA
Sep 7, 2024
UK Regulator Clears Diabetes and Obesity Drugs of Increasing Suicidal Thoughts Risks
Sep 5, 2024
Akums Drugs Advances Global Expansion with Leap into European Markets
Aug 31, 2024
Cingulate Gears Up for Commercialization as FDA Nods to Marketing Approval Application for CTx-1301
Aug 14, 2024
Quoin Pharmaceuticals Advances with Clinical Study on Peeling Skin Syndrome
Aug 6, 2024
Mankind Pharma VP Envisions BSV Portfolio Growth to Rs 5,000 Crores in Coming Years
Jul 29, 2024
Eisai and Biogen's Joint Development, Lecanemab, Progresses in EU Regulatory Review for Alzheimer's Treatment
Jul 27, 2024
NHS Prescription Rates for Novo Nordisk's Wegovy Fall Short Amid Clinic Shortages
Jul 25, 2024
Arcutis Biotherapeutics to Discuss ZORYVE® (Roflumilast Cream 0.15%) FDA Approval in Upcoming KOL Event
Jul 23, 2024
Sanofi's Dupixent Secures EU Approval as Novel COPD Therapy
Jul 4, 2024
Biogen Announces European Approval for Tocilizumab Biosimilar, TOFIDENCE™
Jun 25, 2024
Breakthrough for Type 1 Diabetics: Inhaled Insulin Shows Significant Glycemic Control Improvement
Jun 22, 2024
U.S. Stock Market Sees Mixed Movements with Key Stocks Making Significant Moves
Jun 12, 2024
GENFIT Achieves FDA Approval Milestone with Ipsen's Iqirvo® for Primary Biliary Cholangitis
Jun 11, 2024
Ipsen Achieves FDA Accelerated Approval for Iqirvo® as Innovative PPAR Treatment for Primary Biliary Cholangitis
Jun 11, 2024
Lilly's Tirzepatide Shows Promising Results in MASH Resolution and Fibrosis Improvement
Jun 9, 2024
Emergent BioSolutions' Commitment to Combating the Opioid Crisis Highlights the Importance of National Naloxone Awareness Day
Jun 7, 2024
Biomea Fusion's Diabetes Drug BMF-219 Faces FDA Clinical Hold
Jun 6, 2024
Novo Nordisk Shares Ascend 31% In 2024, Hovering Near Buying Territory
Jun 1, 2024
Amgen and AstraZeneca Showcase Efficacy of Tezspire in Treating COPD Across Diverse Patients
May 21, 2024
Ardelyx Unveils Additional Clinical Data for IBSRELA® at Digestive Disease Week 2024
May 21, 2024
Ardelyx Showcases Further Evidence of IBSRELA® Efficacy at 2024 Digestive Disease Week
May 21, 2024
Rigel Pharmaceuticals RIGL Receives 'Buy' Upgrade from StockNews.com
May 12, 2024
Incannex Healthcare Announces Breakthrough in Opioid Use Disorder Treatment With Pre-IND Meeting Success
May 7, 2024
GSK Announces $35 Monthly Cap on Inhaler Costs for Asthma and COPD Patients
Mar 22, 2024
Retail Traders Shifting Focus from Tech Giants to Pharma Stocks
Mar 9, 2024
Viatris Inc. Partners with Idorsia for Strategic R&D Collaboration in Bringing Forward Potential Blockbusters
Feb 28, 2024
Cardiol Therapeutics Announces Full Patient Enrollment in Phase II MAvERIC-Pilot Study Targeting Recurrent Pericarditis
Feb 22, 2024
The Pneumonia Therapeutics Market Set for Robust Growth, Expected to Reach USD 5.7 Billion by 2031
Feb 19, 2024
Eli Lilly's Prospects with Innovative Treatments Potentially Elevating Its Market Standing
Feb 16, 2024
Class Action Lawsuit Initiated Against Amylyx Pharmaceuticals, Prompting Investor Alert by Bragar Eagel & Squire, P.C.
Feb 11, 2024
CTLA4 Inhibitors Market Projected to Expand by USD 2.23 Billion From 2023 Onwards
Jan 27, 2024
Liquidia Corporation Announces FDA Update on YUTREPIA™ Inhalation Powder NDA
Jan 25, 2024
Liquidia Corporation Announces FDA Update on YUTREPIA™ Inhalation Powder NDA
Jan 25, 2024
Unicycive Therapeutics Announces Upcoming Milestones in Shareholder Update
Jan 23, 2024
Prominent S&P 500 Stocks Surge as 2024 Commences
Jan 14, 2024
Pasithea Therapeutics Kicks Off Phase 1 Trials for Advanced Cancer Treatment with PAS-004
Jan 3, 2024
Bristol Myers Squibb Announces $4.1 Billion Acquisition of RayzeBio
Dec 27, 2023
Cidara Therapeutics Celebrates European Commission Approval for Rezzayo as Stocks Soar
Dec 27, 2023
Bristol Myers Squibb Announces $4.1 Billion Acquisition of RayzeBio; RYZB Shares Skyrocket
Dec 27, 2023
European Commission Revokes Marketing Authorizations for Generic TECFIDERA® Variants; Biogen Affected
Dec 20, 2023
Inhibikase Therapeutics Updates Shareholders on Development Progress
Dec 19, 2023
LITFULO™ Wins Health Canada Nod as First Severe Alopecia Areata Treatment
Dec 5, 2023
Comprehensive Analysis of the 'Long Vax' Phenomenon Following Covid-19 Vaccination
Dec 4, 2023
SciSparc Ltd's SPRC Soars on Launch of Autism Spectrum Disorder Clinical Trial
Nov 25, 2023
Rigel Pharmaceuticals RIGL Stock Rating Demoted by Analysts
Nov 17, 2023